Statement of Retraction: Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling
2024
Retraction of Dexmedetomidine Study
publication
Author Information
Author(s): Feng Yun Yang, Lu Zhang, Yan Zheng, He Dong
Conclusion
The article was retracted due to significant concerns about the integrity of the data and reported results.
Supporting Evidence
- The article was retracted due to significant concerns about the integrity of the data.
- The authors did not provide their original data when asked.
- The retraction was made to maintain the integrity of the scholarly record.
Takeaway
The study about a drug's effect on heart cells was taken back because the authors couldn't prove their results were correct.
Potential Biases
Concerns about data integrity and lack of transparency from the authors.
Limitations
The authors did not provide their original data or necessary supporting information.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website